Update -- Reneo Pharmaceuticals to Participate at the Jefferies Healthcare Conference
- Reneo Pharmaceuticals, Inc. will participate at the Jefferies Healthcare Conference on June 7, 2023. The company's management team will give a presentation at 11:00 a.m. EDT. Investors can access the webcast and presentation on the company's website.
- None.
IRVINE, Calif., May 31, 2023 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases, today announced that the company’s management team will participate at the Jefferies Healthcare Conference.
Jefferies Healthcare Conference
Date: Wednesday, June 7, 2023
Location: Marriott Marquis, New York, NY
Presentation: 11:00 a.m. EDT (webcast)
Links to the webcast and presentation will be posted on the Investors section of the Reneo Pharmaceuticals corporate website.
About Reneo Pharmaceuticals
Reneo is a clinical-stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP). Our lead product candidate, mavodelpar (REN001), is a potent and selective agonist of the peroxisome proliferator-activated receptor delta (PPARδ). Mavodelpar has been shown to increase transcription of genes involved in mitochondrial function, increase fatty acid oxidation, and may increase production of new mitochondria. For additional information, please see reneopharma.com.
Contacts:
Danielle Spangler
Investor Relations
Reneo Pharmaceuticals, Inc.
dspangler@reneopharma.com
David Melamed, Ph.D.
Media Inquiries
Russo Partners, LLC
david.melamed@russopartnersllc.com
FAQ
What is the Jefferies Healthcare Conference?
When will Reneo Pharmaceuticals participate at the conference?
Where can investors access the webcast and presentation?
